Department of Orthopaedic Surgery, Rush University Medical Center, Chicago, IL.
Department of Orthopedic Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA.
J Arthroplasty. 2020 Aug;35(8):2119-2123. doi: 10.1016/j.arth.2020.03.019. Epub 2020 Mar 18.
Failure to achieve clinically significant outcome (CSO) improvement after total hip arthroplasty (THA) imposes a potential cost-to-risk imbalance in the context of bundle payment models. Patient perception of their health state is one component of such risk. The purpose of the current study is to develop machine learning algorithms to predict CSO for the patient-reported health state (PRHS) and build a clinical decision-making tool based on risk factors.
A retrospective review of primary THA patients between 2014 and 2017 was performed. Variables considered for prediction included demographics, medical history, preoperative PRHS, and modified Harris Hip Score. The minimal clinically important difference (MCID) for the PRHS was calculated using a distribution-based method. Five supervised machine learning algorithms were developed and assessed by discrimination, calibration, Brier score, and decision curve analysis.
Of 616 patients, a total of 407 (69.2%) achieved the MCID for the PRHS. The random forest algorithm achieved the best performance in the independent testing set not used for algorithm development (c-statistic 0.97, calibration intercept -0.05, calibration slope 1.45, Brier score 0.054). The most important factors for achieving the MCID were preoperative PRHS, preoperative opioid use, age, and body mass index. Individual patient-level explanations were provided for the algorithm predictions and the algorithms were incorporated into an open access digital application available here: https://sorg-apps.shinyapps.io/THA_PRHS_mcid/.
The current study created a clinical decision-making tool based on partially modifiable risk factors for predicting CSO after THA. The tool demonstrates excellent discriminative capacity for identifying those at greatest risk for failing to achieve CSO in their current health state and may allow for preoperative health optimization.
全髋关节置换术后未能达到临床显著改善(CSO),在捆绑支付模式下可能会导致成本风险失衡。患者对自身健康状况的感知是这种风险的一个组成部分。本研究的目的是开发机器学习算法来预测患者报告的健康状况(PRHS)的 CSO,并基于风险因素构建临床决策工具。
对 2014 年至 2017 年间进行初次全髋关节置换术的患者进行回顾性研究。考虑用于预测的变量包括人口统计学、病史、术前 PRHS 和改良 Harris 髋关节评分。使用基于分布的方法计算 PRHS 的最小临床重要差异(MCID)。开发了五种监督机器学习算法,并通过判别、校准、Brier 评分和决策曲线分析进行评估。
在 616 名患者中,共有 407 名(69.2%)达到了 PRHS 的 MCID。随机森林算法在未用于算法开发的独立测试集中表现出最佳性能(c 统计量为 0.97,校准截距为-0.05,校准斜率为 1.45,Brier 得分为 0.054)。达到 MCID 的最重要因素是术前 PRHS、术前使用阿片类药物、年龄和体重指数。为算法预测提供了个体患者水平的解释,并将算法纳入了此处提供的开放访问数字应用程序:https://sorg-apps.shinyapps.io/THA_PRHS_mcid/。
本研究基于部分可修改的风险因素创建了一种临床决策工具,用于预测全髋关节置换术后 CSO。该工具对识别那些在当前健康状况下最有可能无法达到 CSO 的患者具有出色的判别能力,并且可能允许术前进行健康优化。